Home » John Crison

John Crison

Sep 28, 2007
Premium
John Crison has Joined Simulations Plus as its director of life sciences.
The company, which offers simulation and modeling software for pharmaceutical discovery and development, announced that Crison replaces Michael Bolger, who has “served the company very well” for 11 years.
 
However, Bolger moved 350 miles from company offices in Lancaster, which was no longer in line with company needs.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Here We Are Again

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

In the Pink

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

All Tied Up in a Bow

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

This Week in PNAS

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

Jun
12
Featured Webinar

Bridging the Gap Between Testing and Treatment in Precision Oncology

Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

What's Popular?

In Informatics

  1. Philips, Navican Look to Integrate Genomics, Pathology Data to Deliver Precision Oncology

    Premium

  2. Precision Therapeutics to Acquire Remaining Helomics Shares

  3. Chan Zuckerberg Initiative to Fund Human Cell Atlas Projects

  4. CytoReason's Machine-Learning Model Offers New Insights Into Immune-Related Diseases

    Premium

  5. Partners Builds App Platform to Address Emerging Clinical Needs With Genomic IT

    Premium

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.